A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphoma
Titel:
A Phase Ib multicenter, dose-escalation study of the polyamine analogue PG-11047 in combination with gemcitabine, docetaxel, bevacizumab, erlotinib, cisplatin, 5-fluorouracil, or sunitinib in patients with advanced solid tumors or lymphoma
Auteur:
Murray Stewart, Tracy Von Hoff, Daniel Fitzgerald, Michael Marton, Laurence J. Becerra, Carlos H. Roberto Boyd, Thomas E. Conkling, Paul R. Garbo, Lawrence E. Jotte, Robert M. Richards, Donald A. Smith, David A. Stephenson, Joe J. Vogelzang, Nicholas J. Wu, Hillary H. Casero, Robert A.